Mushrooms have long been recognized for their nutritional value and potential health benefits. Recent research suggests that these edible fungi may also play a role in supporting mental health. A study published in the Journal of Affective Disorders analyzed dietary and mental health data from more than 24,000 U.S. adults between 2005 and 2016 and found that individuals who consumed mushrooms had a lower risk of depression. Mushrooms contain several bioactive compounds—including ergothioneine, antioxidants, anti-inflammatory substances, and nutrients involved in neurological health—that may help protect against oxidative stress and support brain function. While the study observed a significant association between mushroom intake and reduced depression risk, it did not find a clear dose–response relationship. These findings highlight the potential importance of mushrooms as part of a balanced diet and suggest that further research may help clarify their role in mental health and disease prevention.
Bioactive Compounds in Mushrooms and Their Potential Role in Mental Health
Mushrooms contain a variety of bioactive compounds associated with reduced levels of anxiety, including vitamin B12, nerve growth factors, antioxidants, and anti-inflammatory substances. Mushrooms frequently make headlines for their multiple health benefits, as they are not only associated with a reduced risk of cancer but may also help lower the risk of premature death.
Recently, a research report published in the international journal Journal of Affective Disorders indicated that these “superfoods” may also be beneficial for an individual’s mental health. Scientists from Pennsylvania State University and other institutions conducted the study.
In the article, researchers collected and analyzed dietary and mental health data from more than 24,000 American adults between 2005 and 2016. The results showed that individuals who consumed mushrooms had a lower risk of developing depression.
The researchers pointed out that mushrooms contain ergothioneine, an antioxidant that helps protect the body from cellular and tissue damage. Some studies have suggested that antioxidants may help prevent several mental health disorders, such as schizophrenia, bipolar disorder, and depression.
Researcher Dr. Djibril Ba stated that mushrooms are the highest dietary source of the amino acid ergothioneine, an anti-inflammatory compound that humans cannot synthesize. Higher levels of ergothioneine may reduce the risk of oxidative stress in the body, which could in turn decrease the risk of developing depression. White button mushrooms, a commonly consumed mushroom variety in the United States, contain potassium and are believed to help reduce anxiety levels.
Mushroom Consumption and Depression Risk: Findings from Population Data
In addition, other edible mushroom varieties—particularly lion’s mane mushrooms—may stimulate the expression of neurotrophic factors in the body, such as the synthesis of nerve growth factor. This may play an important role in effectively preventing neuropsychiatric disorders, including depression.
According to the researchers, non-Hispanic White women with a college education were more likely to consume mushrooms. The average age of the participants surveyed was 45 years, and the majority (66%) were non-Hispanic White. After considering sociodemographic factors, major risk factors, self-reported diseases, medications, and other dietary variables, the researchers observed a clear association between mushroom consumption and a reduced risk of depression. However, relatively higher mushroom intake did not appear to provide significant additional benefits.
The researchers subsequently conducted a secondary analysis to examine whether replacing one daily serving of red or processed meat with one daily serving of mushrooms could effectively reduce the risk of depression. However, the results indicated that this substitution was not significantly associated with a reduction in depression risk.
Before this study, few investigations had analyzed the relationship between mushroom intake and depression risk in the general population, and most previous studies involved clinical trials with fewer than 100 participants. The researchers noted that the present study highlights the potential of mushroom consumption as a possible strategy to reduce depression and prevent other diseases, suggesting potential clinical significance and importance for public health.
The researchers also pointed out several limitations of the study that may be addressed in future research. The data obtained did not provide details regarding the types of mushrooms consumed, making it impossible to determine the effects of specific mushroom varieties on depression risk. In addition, food codes released by the United States Department of Agriculture were used to estimate mushroom intake, and some entries may have been misclassified or inaccurately recorded.
In summary, the findings of this study suggest that mushroom consumption may be associated with a lower risk of depression in the population; however, the researchers did not observe a dose–response relationship in the study.